In an elderly female hospice patient with hypertension, atrial fibrillation, vascular dementia, prior transient ischemic attack, Crohn’s disease, diabetes, and anxiety who experienced a hypertensive urgency with blood pressure 220/74 mm Hg that fell to approximately 120/74 mm Hg after her usual dose of oral amlodipine, what are the appropriate next management steps?

Management of Hypertensive Episode in an Elderly Hospice Patient

Continue Current Amlodipine Regimen Without Escalation

In this hospice patient whose blood pressure responded appropriately to her usual amlodipine dose (220/74 → 120/74 mmHg), no additional antihypertensive intervention is warranted. 1, 2

---

Immediate Assessment: This Was NOT a Hypertensive Emergency

• The absence of acute target-organ damage (no altered mental status, chest pain, dyspnea, acute neurologic deficits, or visual changes) classifies this episode as hypertensive urgency, not emergency 2, 3
• Hypertensive emergency requires BP >180/120 mmHg WITH acute organ damage (hypertensive encephalopathy, stroke, acute MI, pulmonary edema, aortic dissection, acute kidney injury, or malignant retinopathy); this patient had none 2, 3
• The rate of BP rise matters more than the absolute value—patients with chronic hypertension (like this patient with longstanding hypertension) tolerate higher pressures than previously normotensive individuals 2

---

Why the Current Response Is Appropriate

• Blood pressure normalized with usual-dose amlodipine (from 220/74 to approximately 120/74 mmHg), demonstrating adequate medication efficacy 4
• Amlodipine's 35-50 hour half-life and >24-hour duration of action provide sustained BP control even with occasional missed doses, making it ideal for patients with potential adherence challenges 4
• The isolated systolic hypertension pattern (220/74 mmHg) is typical in elderly patients and was appropriately managed 1

---

Hospice-Specific Management Principles

Goals of Care Alignment

• For older adults with high comorbidity burden and limited life expectancy, clinical judgment and patient preference should guide BP management intensity 1
• In hospice patients, the priority shifts from aggressive BP targets to symptom management and quality of life 1
• Avoid excessive BP lowering that could precipitate cerebral, renal, or coronary ischemia—particularly critical in this patient with vascular dementia and prior TIA 1, 2

Appropriate BP Targets for This Patient

• BP <140/90 mmHg is reasonable for elderly patients with multiple comorbidities, rather than the more aggressive <130/80 mmHg target used in younger, healthier adults 1
• The achieved BP of ~120/74 mmHg is acceptable but avoid diastolic BP <60 mmHg in any older person 5
• Gradual BP normalization over 24-48 hours is preferred over acute reduction 2, 3

---

Monitoring and Follow-Up Recommendations

Short-Term Monitoring (Next 24-48 Hours)

• Monitor for orthostatic hypotension by checking BP supine and standing, as intensive BP control does not typically worsen orthostasis but vigilance is warranted 1
• Assess for symptoms of hypoperfusion: dizziness, confusion worsening beyond baseline, falls, or oliguria 2
• Continue usual amlodipine dose without escalation 4

Ongoing Hospice Management

• No need for additional antihypertensive agents given the appropriate response to current therapy 2, 3
• Home BP monitoring (if feasible in hospice setting) to confirm sustained control and avoid white-coat effect 3
• Reassess medication burden periodically—if BP remains consistently controlled and life expectancy is very limited, consider whether continued antihypertensive therapy aligns with comfort-focused goals 1, 5

---

When to Consider Medication Adjustment

Scenarios Requiring Intervention

• Persistent BP >160/100 mmHg despite adherence to amlodipine, suggesting true resistant hypertension 6
• Recurrent symptomatic hypertensive episodes with headache, visual changes, or confusion 2
• Development of acute target-organ damage (stroke, MI, heart failure, acute kidney injury) 2, 3

If Escalation Were Needed (Not Currently Indicated)

• Add a thiazide diuretic (chlorthalidone 12.5-25 mg daily preferred over hydrochlorothiazide) as the next step, creating the evidence-based combination of ARB + CCB + thiazide 6
• Avoid beta-blockers as monotherapy in elderly patients due to inferior stroke prevention compared to other agents 1

---

Critical Pitfalls to Avoid in This Patient

• Do NOT admit to hospital or ICU—this was hypertensive urgency without target-organ damage, manageable with oral therapy 2, 3
• Do NOT use IV antihypertensives—reserved exclusively for hypertensive emergencies with acute organ damage 2, 3
• Do NOT rapidly lower BP—excessive acute drops >70 mmHg systolic can precipitate cerebral, renal, or coronary ischemia, especially dangerous in patients with vascular dementia and prior TIA 1, 2, 5
• Do NOT use immediate-release nifedipine—causes unpredictable precipitous BP drops, stroke risk, and death 2, 3
• Do NOT overlook medication adherence—verify the patient is taking amlodipine consistently, as non-adherence is the most common cause of apparent treatment resistance 6

---

Special Considerations for This Patient's Comorbidities

Vascular Dementia and Prior TIA

• Amlodipine may provide neuroprotective benefits—associated with decreased dementia risk in hypertensive individuals >60 years (HR 0.60, p<0.001) 7
• Maintain cerebral perfusion—avoid aggressive BP lowering that could worsen cognitive function or precipitate ischemic events 1, 5
• BP variability reduction with amlodipine's long half-life may protect against recurrent TIA 4

Atrial Fibrillation

• Ensure anticoagulation status is appropriate for stroke prevention (CHA₂DS₂-VASc score includes prior TIA, age ≥75, hypertension, vascular disease, diabetes—this patient scores ≥5) 1
• Warfarin or DOAC therapy should be continued unless contraindicated by bleeding risk or goals of care 1

Diabetes and Chronic Kidney Disease

• Amlodipine does not worsen glycemic control or kidney function—safe choice in this population 4
• Monitor for hyperglycemia during acute stress, which may temporarily require insulin adjustment 2

---

Documentation and Communication

• Document the BP episode, response to usual medication, absence of target-organ damage, and decision to continue current therapy 2
• Communicate with hospice team about BP goals aligned with comfort-focused care 1
• Educate caregivers about when to seek urgent evaluation (new confusion, chest pain, severe headache, visual changes, focal weakness) versus when to observe 2, 3